Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr 19;119(16):3844-53.
doi: 10.1182/blood-2011-10-384057. Epub 2011 Nov 18.

Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells

Affiliations

Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells

Tomomi Toubai et al. Blood. .

Abstract

It is currently thought that acute GVHD cannot be elicited in the absence of Ag presentation by radiosensitive host hematopoietic-derived APCs after allogeneic BM transplantation. Because clinical data suggest that sex-mismatched H-Y Ags may be important minor histocompatibility Ags for GVH responses, we directly tested their relevance and ability to initiate GVHD when presented by either the hematopoietic- (host or donor) or the nonhematopoietic-derived APCs. H-Y minor Ag incompatibility elicited both CD4(+) and CD8(+) T-cell driven GVHD lethality. Studies with various well-established BM chimera recipients, in contrast to the current views, have reported that in the absence of functional radiosensitive host hematopoietic-derived APCs, H-Y Ag presentation by either the donor hematopoietic-derived or the host nonhematopoietic-derived APCs is sufficient for inducing GVHD. Our data further suggest that infusion of sufficient numbers of alloreactive donor T cells will induce GVHD in the absence of radiosensitive host hematopoietic-derived APCs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Single H-Y Ag-specific T cells induce CD8+ and CD4+ T cell–mediated GVHD. (A) Survival in CD8+-mediated GVHD after infusion of 1 × 106 CD8+ T cells from MataHari donors. Data are from 1 of 4 similar experiments. (B-E) GVHD analysis on day 5. Data are from 1 of 3 similar experiments. (B) Histopathologic analysis of liver (i-ii) and GI tract (iii-iv) by H&E stain (left) and scores (right). (C) Serum levels of TNF-α, IFN-γ, and IL-17A (ND indicates not detected). (D) Allo-H-Y Ag-specific donor CD45.2+CD8+ T-cell expansion in spleen. (E) Donor CD45.2+CD8+IFN-γ+ in spleen with representative histogram of IFN-γ expression gated by CD45.2+CD8+ T cells (left) and the absolute number of CD45.2+CD8+IFN-γ+ T cells in spleen (right). (F-G) Survival CD4+ GVHD. Data shown are from 1 of 3 similar experiments.
Figure 2
Figure 2
Donor T-cell precursor frequency is critical for induction of GVHD. Rachel T cells were transplanted along with TCD BM from B6♀ donors into lethally irradiated syngeneic B6♀ or allogeneic B♂ animals. The recipients were monitored for (A) survival and GVHD score. (B) Histopathology scores for liver and GI tract. (C) Skin H&E (left) and score (right). Data are from 1 of 3 similar experiments.
Figure 3
Figure 3
Polyclonal H-Y Ag-specific T cells induce GVHD. (A-B) Experimental schema: polyclonal T cells from WT B6♀ mice that are specific for H-Y Ags were generated after in vivo and subsequent ex vivo priming. These T cells were then transplanted along with TCD BM from B6♀ donors into lethally irradiated syngeneic B6♀ or allogeneic B6♂ animals. The animals were monitored for (C) survival and GVHD score. Data are from 2 combined experiments. **P < .01 compared with female recipients. (D) GVHD histopathology, scores of liver and GI tract and (E) lymphocyte infiltration in the spleen, intestine, and liver. Data are from 1 of 2 similar experiments. (F) Unprimed B6♀ T cells induce GVHD in allogeneic B6♂ recipients. CD90+ T cells (2 × 106 or 15 × 106) donor T cells were harvested from WT B6 female donors and transplanted without priming along with TCD BM into irradiated (11 Gy) syngeneic B6♀ and allogeneic B6♂ animals. The animals were monitored for clinical GVHD severity. (G) Histopathologic analysis, GVHD damage scores of liver and GI tract 70 days after allo-hematopoietic cell transplantation
Figure 4
Figure 4
Alloantigen expression and GVHD. (A) Experimental schema: the F→F, F→M, and M→F chimeras were generated such that male Ags are either not expressed or expressed only on the target tissues or only on the hematopoietic-derived cells. These chimeras were then irradiated and transplanted with Marilyn T cells along with TCD WT B6♀ BM cells and were monitored for (B) survival and (C) Serum levels of TNF-α, IFN-γ, and IL-17A on day 5. Data are from 1 of 2 similar experiments.
Figure 5
Figure 5
Presentation by donor and host nonhematopoietic APCs. (A) Experimental schema: B6♂ animals underwent thymectomy and were used for generation of (class II−/−♀→B6♂) chimeras. Three months later, these chimeras were irradiated and transplanted with either B6 or Marilyn T cells and monitored for (B) survival. Data are from 2 combined experiments. (C) Donor APCs alone stimulate GVH responses. Experimental schema: TCD BM from either WT or class II−/− B6♀ were transplanted along with WT or Marilyn T cells into lethally irradiated BALB/c males. (D) Total donor H2Kd+CD4+ T-cell expansion, H2kd+CD4+IFN-γ+ T-cell number, and serum IFN-γ concentration from day 7. Data are from 1 of 2 similar experiments. (E-I) Induction of GVHD in the absence of donor and radiosensitive host hematopoietic-derived APCs. (E) Experimental schema: B6Ly5.2 female and male animals were lethally irradiated, treated with anti–natural killer (NK) Ab and transplanted with either WT B6 or β2m−/− BM. Three months later, these chimeras were transplanted with TCD BM from either WT or β2m−/− B6♀ animals along with MataHari T cells. The animals were monitored for (F) survival and (G) clinical score. Data from 1 of 3 similar experiments are shown. (H) Donor CD45.2+CD8+ T cells expansion in spleen and (I) histopathology scores of liver and GI tract. Data from 1 of 2 similar experiments are shown.
Figure 6
Figure 6
Alloantigen presentation and GVHD in the absence of radiosensitive host hematopoietic-derived APCs. (A) Experimental schema: β2m−/−♂→B6♂ chimeras were generated as described in “Methods.” They were then irradiated with 9 Gy and transplanted with TCD BM from β2m−/− animals along with T cells from B6♂ or BALB/c♀ donors and analyzed for donor T-cell expansion. (B) Total donor CD45.1+CD8+ or H2kd+CD8+ T cells expansion. (C) Donor CD8+IFN-γ+ T cell number and (D) serum levels of IFN-γ. Data from 1 of 2 similar experiments are shown. (E) GVH responses induced by host nonhematopoietic APCs depend on T-cell precursor frequency. Survival and GVHD score. Data from 1 of 2 similar experiments are shown. (F-H) Male nonhematopoietic cells can stimulate both H-Y Ag-specific T cells and allogenic T cells. (F-G) Marilyn CD4 T cells against male liver endothelial cells (H) and epithelial cells of small intestine (G). (H) B6 male–derived liver endothelial cells can stimulate allogeneic BALB/c T cells. (I-J) Class II expression on liver endothelial cells gated by CD146+ cells, (right) naive and (left) IFN-γ stimulation for 48 hours (I). (J) Bar graph of class II expression on liver endothelial cells. Data are from 1 of 3 similar experiments.

Comment in

  • MataHari reveals secrets of GVHD.
    Hanash AM. Hanash AM. Blood. 2012 Apr 19;119(16):3656-7. doi: 10.1182/blood-2012-01-394536. Blood. 2012. PMID: 22517875 No abstract available.

References

    1. Perreault C, Jutras J, Roy DC, Filep JG, Brochu S. Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease. J Clin Invest. 1996;98(3):622–628. - PMC - PubMed
    1. Meunier MC, Delisle JS, Bergeron J, Rineau V, Baron C, Perreault C. T cells targeted against a single minor histocompatibility antigen can cure solid tumors. Nat Med. 2005;11(11):1222–1229. - PubMed
    1. Fontaine P, Roy-Proulx G, Knafo L, Baron C, Roy DC, Perreault C. Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease. Nat Med. 2001;7(7):789–794. - PubMed
    1. Korngold R, Leighton C, Mobraaten LE, Berger MA. Inter-strain graft-vs.-host disease T-cell responses to immunodominant minor histocompatibility antigens. Biol Blood Marrow Transplant. 1997;3(2):57–64. - PubMed
    1. Blazar BR, Roopenian DC, Taylor PA, Christianson GJ, Panoskaltsis-Mortari A, Vallera DA. Lack of GVHD across classical, single minor histocompatibiliTy (miH) locus barriers in mice. Transplantation. 1996;61(4):619–624. - PubMed

Publication types

MeSH terms